Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis
- PMID: 2447572
- PMCID: PMC2428395
- DOI: 10.1136/pgmj.63.742.617
Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis
Abstract
Thirteen patients with Raynaud's phenomenon secondary to systemic sclerosis received three 8-hour infusions of a synthetic prostacyclin analogue (Iloprost) on consecutive days and were followed-up over a period of 10 weeks during the winter of 1985/86. Six weeks after infusion, digital peripheral vascular resistance had fallen (P less than 0.05) and dicrotic notch proportion of pulse amplitude increased (P less than 0.05). Digital blood flow and pulse amplitude (measured by photoplethymography) were also increased but did not reach statistical significance. The trend of improvement in these blood flow parameters was still evident after 10 weeks. The number of cutaneous lesions (digital ulcers, etc) fell from 26 lesions before infusion to only 7 lesions by the end of the study, confirming the subjective improvement reported by the patients.
Similar articles
-
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.BMJ. 1989 Mar 4;298(6673):561-4. doi: 10.1136/bmj.298.6673.561. BMJ. 1989. PMID: 2467711 Free PMC article. Clinical Trial.
-
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.J Rheumatol. 1992 Sep;19(9):1407-14. J Rheumatol. 1992. PMID: 1279170 Clinical Trial.
-
Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.Ann Rheum Dis. 1988 Jan;47(1):43-7. doi: 10.1136/ard.47.1.43. Ann Rheum Dis. 1988. PMID: 2449871 Free PMC article. Clinical Trial.
-
[Iloprost for the treatment of systemic sclerosis].Presse Med. 2008 May;37(5 Pt 2):831-9. doi: 10.1016/j.lpm.2007.06.016. Epub 2007 Nov 26. Presse Med. 2008. PMID: 18035518 Review. French.
-
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.Semin Arthritis Rheum. 2019 Feb;48(4):686-693. doi: 10.1016/j.semarthrit.2018.03.019. Epub 2018 Apr 4. Semin Arthritis Rheum. 2019. PMID: 29706243
Cited by
-
Raynaud's syndrome.BMJ. 1990 Mar 3;300(6724):553-5. doi: 10.1136/bmj.300.6724.553. BMJ. 1990. PMID: 1691027 Free PMC article. Review. No abstract available.
-
[Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].Z Rheumatol. 2013 Dec;72(10):960-9. doi: 10.1007/s00393-013-1270-2. Z Rheumatol. 2013. PMID: 24337198 Review. German.
-
[Treatment of therapy-resistant acral ulcers with iloprost].Hautarzt. 2004 Dec;55(12):1150-3. doi: 10.1007/s00105-004-0844-y. Hautarzt. 2004. PMID: 15568132 Clinical Trial. German.
-
Management of Raynaud's phenomenon. Focus on newer treatments.Drugs. 1989 May;37(5):700-12. doi: 10.2165/00003495-198937050-00005. Drugs. 1989. PMID: 2663416 Review.
-
Pharmacotherapy of Raynaud's phenomenon.Drugs. 1996 Nov;52(5):682-95. doi: 10.2165/00003495-199652050-00006. Drugs. 1996. PMID: 9118818 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical